Early prediction of macular neovascularization phenotypes and prognostic evolution

Area of Science:

• Ophthalmology
• Retinal Diseases
• Age-Related Macular Degeneration (AMD)

Background:

• Macular neovascularization (MNV) is a sight-threatening complication of age-related macular degeneration (AMD).
• Identifying predictors of MNV phenotypes and outcomes is crucial for patient management.
• Understanding the heterogeneity of MNV is essential for developing targeted therapies.

Purpose of the Study:

• To identify baseline predictors of different macular neovascularization (MNV) phenotypes.
• To investigate prognostic outcomes, including visual acuity changes, macular atrophy (MA), and fibrosis.
• To establish predictive models for MNV subtypes and their progression.

Main Methods:

• Retrospective observational cohort study of 102 eyes from 97 patients with intermediate AMD converting to MNV.
• Analysis of baseline features: age, drusen, reticular pseudodrusen (RPD), subfoveal choroidal thickness (SFCT), and central retinal thickness (CRT).
• Development of predictive models using Cox regression and generalized linear models.

Main Results:

• Type 1 MNV occurred in 68.6%, type 2 in 15.7%, and type 3 in 15.7% of eyes.
• SFCT predicted type 2 MNV (thicker choroid predisposed); age predicted type 3 MNV.
• Type 2 MNV had the highest fibrosis rate (71.4%). Age and best-corrected visual acuity (BCVA) predicted vision loss; drusen showed a protective effect.
• Baseline SFCT reduced the risk of outer retinal atrophy.

Conclusions:

• SFCT is a key indicator for type 2 MNV, and aging is a primary predictor for type 3 MNV.
• These findings can enhance early identification and personalized management of MNV phenotypes.
• Optimizing treatment strategies can mitigate complications like fibrosis and atrophy, improving visual outcomes.